Acetylsalicylic acid Recruiting Phase 2 Trials for Tertiary Prevention in Colon Cancer Prevention

Indications	Status	Purpose	Phase
DBCOND0082929 (Tertiary Prevention in Colon Cancer)	Recruiting	Prevention	2

clinicaltrials.gov Identifier	Title	Drugs
NCT03047837	A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients.	Acetylsalicylic acid (DB00945) Metformin (DB00331)